Potential of mesenchymal stem cell therapy.

Area of Science:

• Stem cell biology
• Immunology
• Regenerative Medicine

Background:

• Mesenchymal stem cells (MSCs) possess differentiation potential into mesenchymal tissues and the hematopoietic stem cell niche.
• MSCs exhibit potent immunosuppressive properties, making them candidates for therapeutic applications.

Purpose of the Study:

• To review recent data on mesenchymal stem cells (MSCs) and identify properties of therapeutic significance.
• To evaluate the potential of MSCs in regenerative medicine and autoimmune disease treatment.

Main Methods:

• Literature review of recent scientific data on mesenchymal stem cells (MSCs).
• Analysis of preclinical (animal models) and clinical findings related to MSC therapy.

Main Results:

• MSCs show encouraging results in accelerating myocardial infarction recovery, improving growth in osteogenesis imperfecta, and treating graft-versus-host disease, rheumatoid arthritis, and multiple sclerosis in models.
• Clinical applications of MSCs are promising for regenerative medicine and autoimmune diseases, but require caution due to potential roles in cancer stem cell maintenance.

Conclusions:

• Mesenchymal stem cells (MSCs) are of significant therapeutic interest, driving initiatives to test their clinical potential.
• Further investigation is crucial to fully characterize MSC phenotype, elucidate mechanisms of action, and optimize in-vitro expansion for safe and effective clinical applications.